Search - tctmd.com

Displaying 21 - 40 of 224

Sort: Relevancy | Date

Presentation THT 2026

Device Transitions — Bridge to Bridge

Presenter: Francis D. Pagani

March 03, 2026

Presentation THT 2026

Translational Validation of the SEPRDD (Sensing Pressure Releasing Diuretic Drug) - Heart Failure Device : Bridging Bench to Large Animal Models for Heart Failure Therapy

Presenter: Vasim Panwar

March 03, 2026

Presentation THT 2026

Moving Beyond a Decade of HM3: Devices of the Future

Presenter: Ivan Netuka

March 03, 2026

News Conference News THT 2026

AI-Enabled Virtual HF Care May Help Boost GDMT, Stabilize Weight

Todd Neale

March 03, 2026

Presentation THT 2026

Percutaneous Pericardiotomy as a Treatment for HFpEF (Heart Failure Solutions)

Presenter: Barry Borlaug

March 03, 2026

Presentation THT 2026

Levosimendan: Mechanisms and Clinical Effects as a Treatment for PH-HFpEF

Presenter: Sanjiv J. Shah

March 03, 2026

Presentation THT 2026

Ultrasound Pulmonary Artery Denervation as a Treatment for Heart Failure (Gradient Medical)

Presenter: Alex Rothman

March 03, 2026

Presentation THT 2026

Radiofrequency Pulmonary Artery Denervation for Heart Failure (Pulnovo)

Presenter: Giora Weisz

March 03, 2026

Presentation THT 2026

Splanchnic Nerve Ablation for Treatment of HF Across the Spectrum of LV EFs

Presenter: Parag Goyal

March 03, 2026

Presentation THT 2026

Renal Denervation Beyond HTN: Implications and the Intersection Between Heart Failure and Fatty Liver

Presenter: David E. Kandzari

March 03, 2026

Presentation THT 2026

The Role of the Myocardium in HFpEF

Presenter: Michael R. Zile

March 03, 2026

Presentation THT 2026

Preclinical Results of a Novel, Percutaneous Device to Reapproximate and Reshape the Right Ventricle in Functional Tricuspid Regurgitation with Right Ventricular Dysfunction

Presenter: Michael I. Brener

March 03, 2026

Presentation THT 2026

Results From The International MISSION Re-BEAT Feasibility Trial Using A Pulsatile, Soft Robotic Biventricular MCS Device That Avoids Blood Contact In Heart Failure Patients With Reduced Ejection Fraction

Presenter: Stephen Wildhirt

March 03, 2026

Presentation THT 2026

The Magenta Elevate Device

Presenter: Perwaiz M. Meraj

March 03, 2026

Presentation THT 2026

Updates on the Spectrum of Impella Devices

Presenter: Jane E. Wilcox

March 03, 2026

Presentation THT 2026

The Landscape of Devices Under Development for Percutaneous Mechanical Support

Presenter: Ajay J. Kirtane

March 03, 2026

Presentation THT 2026

Devices Are Not Enough: Revitalizing Development of New Drugs for Cardiogenic Shock

Presenter: Alexandre Mebazaa

March 03, 2026

Presentation THT 2026

Reducing Renal Venous Pressure to Improve Urine Output: Overview of Devices, Current Status, and Future Directions

Presenter: Arvind Bhimaraj

March 03, 2026

Presentation THT 2026

Sex- and Race‑Based Differences in Outcomes Following Left Ventricular Assist Device Explant: A VAD Wean Registry Analysis

Presenter: Toluwalase Awoyemi

March 03, 2026

Presentation THT 2026

What Needs to be Shown in Studies of ADHF Devices to Gain FDA Approval and Adoption Into Clinical Practice

Presenter: G. Michael Felker

March 03, 2026

Advertisement

Device Transitions — Bridge to Bridge

Translational Validation of the SEPRDD (Sensing Pressure Releasing Diuretic Drug) - Heart Failure Device : Bridging Bench to Large Animal Models for Heart Failure Therapy

Moving Beyond a Decade of HM3: Devices of the Future

AI-Enabled Virtual HF Care May Help Boost GDMT, Stabilize Weight

Percutaneous Pericardiotomy as a Treatment for HFpEF (Heart Failure Solutions)

Levosimendan: Mechanisms and Clinical Effects as a Treatment for PH-HFpEF

Ultrasound Pulmonary Artery Denervation as a Treatment for Heart Failure (Gradient Medical)

Radiofrequency Pulmonary Artery Denervation for Heart Failure (Pulnovo)

Splanchnic Nerve Ablation for Treatment of HF Across the Spectrum of LV EFs

Renal Denervation Beyond HTN: Implications and the Intersection Between Heart Failure and Fatty Liver

The Role of the Myocardium in HFpEF

Preclinical Results of a Novel, Percutaneous Device to Reapproximate and Reshape the Right Ventricle in Functional Tricuspid Regurgitation with Right Ventricular Dysfunction

Results From The International MISSION Re-BEAT Feasibility Trial Using A Pulsatile, Soft Robotic Biventricular MCS Device That Avoids Blood Contact In Heart Failure Patients With Reduced Ejection Fraction

The Magenta Elevate Device

Updates on the Spectrum of Impella Devices

The Landscape of Devices Under Development for Percutaneous Mechanical Support

Devices Are Not Enough: Revitalizing Development of New Drugs for Cardiogenic Shock

Reducing Renal Venous Pressure to Improve Urine Output: Overview of Devices, Current Status, and Future Directions

Sex- and Race‑Based Differences in Outcomes Following Left Ventricular Assist Device Explant: A VAD Wean Registry Analysis

What Needs to be Shown in Studies of ADHF Devices to Gain FDA Approval and Adoption Into Clinical Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content